Phathom Pharmaceuticals Inc（PHAT）のニュースとイベントPHATPhathom Pharmaceuticals Inc

Major Averages Decline as Oil Prices Surge

The major averages closed broadly lower as oil prices jumped and investors increasingly demand evidence that massive capital investments for AI will translate into sustainable profits. Next week's results from Microsoft, Alphabet and Amazon are likely to provide important signals in that ongoing debate, which is key to the market's direction.Meanwhile, oil prices are surging once again, surpassing the $100 per barrel threshold as uncertainty over efforts to resume U.S.-Iran negotiations raises concerns about further supply disruptions.Get caught up quickly on the top news and calls moving stocks with these five Top Five lists.1. STOCK NEWS:SpaceXis seeking to secure at least 80,000 cell sites across the U.S. and is in talks with Crown Castleto achieve that goal as the company aims to establish a nationwide wireless carrier, Bloomberg reportsAmerican Expressreported upbeat Q3 earnings, provided guidance for FY26, and announced it will cut 5% of its workforce as part of a restructuring effortApple'snew foldable iPhone Duo is arriving in stores FridayWestern Digitalreported better-than-expected Q1 results and provided an upbeat outlook for Q2Bristol Myersdisclosed that one patient with highly active relapsing multiple sclerosis experienced a fatal event of septic pneumonia in an early stage trial2. WALL STREET CALLS:Phillip Securities upgraded SpaceXto Buy from SellNorwegian Cruise Linedowngraded to Underweight at JPMorgan ahead of Q3 reportJPMorgan upgraded Skydanceto Neutral from UnderweightDeckers Outdoordowngraded to Underweight at Piper SandlerMSC Industrialupgraded to Buy at Jeffries3. AROUND THE WEB:The Trump administration will remove 50% tariffs on certain Canadian products on certain agricultural and forestry products, WSJ reportsAn Australian federal judge has ruled that Applemust let Australian iPhone users install apps from third-party app stores starting March 1, 2027, 9to5Mac saysA Micronlabor union staged Taiwan's first-ever strike in the semiconductor industry on Thursday, Nikkei Asia reportsCitihas received Chinese regulatory approval to establish a wholly owned securities business in Shanghai, Reuters reportsInstacartis working with bankers to explore a sale, The Information reports4. MOVERS:RingCentralgains after reporting Q3 results, providing guidance for Q4, and raising its outlook for FY26Rithm Capitalincreases after reporting Q3 results, with EPS and revenue beating consensusBloom Energyfalls after reporting Q3 results and raising its outlook for FY26Phathom Pharmaceuticalslower after giving an update on its litigation filed by BDR PharmaceuticalsTango Therapeuticsdeclines after announcing results from its ongoing study of vopimetostat5. EARNINGS/GUIDANCE:Booz Allenreported Q2 results and raised its guidance for FY27Flagstar Bankreported Q3 results and lowered its outlook for FY26 and FY27First National Corp.reported Q3 results, with CEO Scott Harvard noting he was "extremely pleased with our record financial performance"LKQreported preliminary Q3 results and withdrew its guidance for FY26Autolivreported Q3 results and reaffirmed its guidance for FY26INDEXES:The Dow fell 652.82, or 1.23%, to 52,215.16, the Nasdaq lost 53.52, or 0.21%, to 25,955.34, and the S&P 500 declined 39.75, or 0.52%, to 7,623.68.

Cantor Fitzgerald Maintains Overweight on Phathom as Stock Drops 23%

After Phathom Pharmaceuticals announced that BDR Pharmaceuticals filed a suit against the FDA, challenging the agency's refusal to receive an abbreviated new drug application that referenced Phathom's new drug application for Voquezna, Cantor Fitzgerald said the firm appreciates that stocks with ongoing lawsuits can "create overhang situations." While BDR alleges that the FDA has improperly applied the GAIN Act to extend Phathom's exclusivity for Voquezna, the firm sees a low likelihood of the FDA reversing its stance on updating the Orange Book listings and estimates the company "still has 6+ years of selling the therapy without any competition." Cantor keeps an overweight on Phathom shares, which are down 23% to $5.38 in afternoon trading.

Dow Jones Falls Nearly 1%, Nasdaq Edges Up

The major averages were mixed near noon, with the Dow roughly 1% lower but the Nasdaq up fractionally as markets look to stabilize after a sharp technology-led selloff. Investors are increasingly demanding evidence that massive capital investments will translate into sustainable profits, with next week's results from Microsoft, Alphabet and Amazon likely to provide important signals. Telecommunications stocks are also in focus after reports that SpaceX is discussing plans to launch a nationwide wireless carrier.Meanwhile, oil prices are surging once again, surpassing the $100 per barrel threshold as uncertainty over efforts to resume U.S.-Iran negotiations raises concerns about further supply disruptions.Get caught up quickly on the top news and calls moving stocks with these five Top Five lists.1. STOCK NEWS:SpaceXis seeking to secure at least 80,000 cell sites across the U.S. and is in talks with Crown Castleto achieve that goal as the company aims to establish a nationwide wireless carrier, Bloomberg reportsAmerican Expressreported upbeat Q3 earnings and provided guidance for FY26Meanwhile, American Express also announced it will cut 5% of its workforce globally as part of a restructuring effortApple'snew foldable iPhone Duo is arriving in stores FridayWestern Digitalreported better-than-expected Q1 results and provided an upbeat outlook for Q22. WALL STREET CALLS:Phillip Securities upgraded SpaceXto Buy from SellNorwegian Cruise Linedowngraded to Underweight at JPMorgan ahead of Q3 reportJPMorgan upgraded Skydanceto Neutral from UnderweightDeckers Outdoordowngraded to Underweight at Piper SandlerMSC Industrialupgraded to Buy at Jeffries3. AROUND THE WEB:An Australian federal judge has ruled that Applemust let Australian iPhone users install apps from third-party app stores starting March 1, 2027, 9to5Mac saysA Micronlabor union staged Taiwan's first-ever strike in the semiconductor industry on Thursday, Nikkei Asia reportsCitihas received Chinese regulatory approval to establish a wholly owned securities business in Shanghai, Reuters reportsGeneral Motorshas cancelled a long-term supply deal with a US rare-earth magnet manufacturer, and the two companies are now working to settle the dispute, Reuters saysRobinhood Venturesinvested $10M in Cognition after committing $75M to OpenAI, reflecting its view that AI coding tools can coexist in a competitive market rather than produce a single winner, Fortune says4. MOVERS:RingCentralgains after reporting Q3 results, providing guidance for Q4, and raising its outlook for FY26Rithm Capitalincreases after reporting Q3 results, with EPS and revenue beating consensusBloom Energyfalls after reporting Q3 results and raising its outlook for FY26Phathom Pharmaceuticalslower after giving an update on its litigation filed by BDR PharmaceuticalsTango Therapeuticsdeclines after announcing results from its ongoing study of vopimetostat5. EARNINGS/GUIDANCE:Booz Allenreported Q2 results and raised its guidance for FY27Flagstar Bankreported Q3 results and lowered its outlook for FY26 and FY27First National Corp.reported Q3 results, with CEO Scott Harvard noting he was "extremely pleased with our record financial performance"LKQreported preliminary Q3 results and withdrew its guidance for FY26Autolivreported Q3 results and reaffirmed its guidance for FY26INDEXES:Near midday, the Dow was down 494.33, or 0.94%, to 52,373.65, the Nasdaq was up 75.00, or 0.29%, to 26,083.86, and the S&P 500 was down 8.49, or 0.11%, to 7,654.94.